University of New Hampshire: Venom of cone snail could lead to diabetes treatments [View all]
DURHAM The tapered cone shell is popular among seashell collectors for its colorful patterns, but the smooth mottled shells are also home to the cone snail which is capable of spewing a potent insulin-like venom that can paralyze its prey. Researchers at the University of New Hampshire have found that variants of this venom, known as cone snail insulin (Con-Ins), could offer future possibilities for developing new fast-acting drugs to help treat diabetics.
Diabetes is rising at an alarming rate and its become increasingly important to find new alternatives for developing effective and budget-friendly drugs for patients suffering with the disease, said Harish Vashisth, associate professor of chemical engineering.
Our work found that the modeled Con-Ins variants, or analogs, bind even better to receptors in the body than the human hormone and may work faster which could make them a favorable option for stabilizing blood sugar levels and a potential for new therapeutics.
In their study, recently published in the journal Proteins: Structure, Function, and Bioinformatics, researchers looked more closely at the cone snail venom which induces a hypoglycemic reaction that lowers blood sugar levels. Unlike insulin made in the body, the venoms peptide sequence which allows it to bind to human insulin receptors is much shorter.
Read more: https://www.conwaydailysun.com/news/local/unh-venom-of-cone-snail-could-lead-to-diabetes-treatments/article_71ebc888-48c0-11ec-a0d9-df67eed899ea.html